Which of the following drug is commonly used in treatment for cancer associated thromboembotismt
(A) Low molecular weight heparin (B) anti-thrombin III inhibitors (C) Direct Xainhibitors (D) Warfarin
(A) Ans: A. Low molecular weight heparinCurrent guideline-endorsed therapy options for cancer-associated thrombosis include low molecularweight heparin (LMWH), unfractionated heparin (UFH), warfarin & fondaparinux.All current guidelines recommend LMWH for at least 3-6 months in cancer-associated VTE.